logo
Select company
Select metric
Ticker Information

Ticker

ABP

Company Name

ABPRO HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABPRO HOLDINGS INC - Enterprise Value over EBITDA Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABP - EV/EBITDA Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)Enterprise ValueEnterprise Value over EBITDA
6/30/2025$ -10.56M$ 22.24M0
3/31/2025$ -8.18M$ 17.95M0
12/31/2024$ -6.22M$ 14.07M0
9/30/2024$ -18.06M$ 156.54M0
6/30/2024$ -1.23M$ 92.81M0
3/31/2024$ 203.81K$ 103.05M505.6
12/31/2023$ 4M$ 89.19M22.3
9/30/2023$ 6.04M$ 115.52M19.13
6/30/2023$ 6.8M$ 112.82M16.59
3/31/2023$ 5.49M$ 112.89M20.57
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ABPRO HOLDINGS INC's latest trailing twelve months (TTM) EV/EBITDA stands at 0.
  • Over the past 5 years, ABPRO HOLDINGS INC's average EV/EBITDA has been 135.25.
  • The median EV/EBITDA for ABPRO HOLDINGS INC during this period was 21.44
  • ABPRO HOLDINGS INC reached its highest EV/EBITDA over the past 5 years at 505.6.
  • The lowest EV/EBITDA recorded by ABPRO HOLDINGS INC in the same timeframe 16.59

ABPRO HOLDINGS INC's EV/EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/EBITDA Benchmarks
CompanyEV/EBITDA
SABS : SAB BIOTHERAPEUTICS INC -HCWB : HCW BIOLOGICS INC -NXL : NEXALIN TECHNOLOGY INC -CTXR : CITIUS PHARMACEUTICALS INC -LIXT : LIXTE BIOTECHNOLOGY HOLDINGS INC -CVKD : CADRENAL THERAPEUTICS INC -VIVS : VIVOSIM LABS INC -AIM : AIM IMMUNOTECH INC -BCTX : BRIACELL THERAPEUTICS CORP 2.03BGMS : BIO GREEN MED SOLUTION INC -

Definition of Enterprise Value over EBITDA

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
EV / EBITDA
(=) EV/EBITDA
EV/EBITDA for ABPRO HOLDINGS INC is calculated as follows: EV [ $ 373.23M ] / EBITDA [ $ -1.79K ]
(=) EV/EBITDA [ 0 ]

ABP - Enterprise Value over EBITDA, Last 5 years

16.59

Minimum

Jun 30, 2023

505.6

Maximum

Mar 31, 2024

135.25

Average

21.44

Median

EV/EBITDA Benchmark Analysis

The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.48 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
filtered constituents2.44K
min0.01
max40.82
average13.48
median11.75
std7.65